Market Research Reports - Research and Markets

Welcome - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.


	Select a currency for use throughout the site

Search Results

Your Search for 'Strategic Perspectives : Endometriosis' returned 4 results - Page 1 of 1

Endometriosis - Global Strategic Business Report
Global Industry Analysts, Inc., April 2011, Pages: 346 ENDOMETRIOSIS A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS 1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONs 1

Endoscopy Systems - Global Strategic Business Report
Global Industry Analysts, Inc., Oct 2011, Pages: 584 37 Intubation Endoscopes 38 Otoscopy 38 Sinoscopy 38 Pharyngolaryngoscopy 38 Obstetrics/Gynecology 38 Fallopian & Ovarian Laparoscopy 38 Endometriosis 39 Tubal Ligation 39 Vagina Creation 39

D-Amino Acids - Global Strategic Business Report
Global Industry Analysts, Inc., Aug 2011, Pages: 224 antibiotics, such as Amoxicillin (D-4-hydroxyphenylglycine) and Ampicillin (D-phenylglycine) that possess a broad anti-microbial range. The drug Nafarelin that is indicated for the treatment of endometriosis

Human Reproductive Technologies - Global Strategic Business Report
Global Industry Analysts, Inc., Oct 2006, Pages: 496 TECHNOLOGIES A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data

Results:

First -

Prev -

1 -

Next -

Last

For enquiries please call us on:

+353-1-415-1241 (GMT Office Hours)

1-800-526-8630 (US/Canada Toll Free)

1-917-300-0470 (EST Office Hours)